We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$12.3B
AUM Growth
+$229M
Cap. Flow
-$342M
Cap. Flow %
-2.78%
Top 10 Hldgs %
11.52%
Holding
627
New
166
Increased
116
Reduced
155
Closed
161

Sector Composition

Rank Sector Weight
1 Technology 14.15%
2 Healthcare 12.62%
3 Financials 12.54%
4 Industrials 12.05%
5 Consumer Discretionary 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AOS icon
376
A.O. Smith
AOS
$8.69B
$2.59M 0.02%
+50,710
New +$2.52M
SFUN
377
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$2.57M 0.02%
15,763
-7,297
-32% -$1.19M
FOMX
378
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$2.49M 0.02%
502,579
-151,262
-23% -$1.46M
TIG
379
DELISTED
TiGenix American Depositary Shares
TIG
$2.47M 0.02%
158,138
-1,862
-1% -$28K
NGNE icon
380
Neurogene
NGNE
$707M
$2.44M 0.02%
7,308
-6,410
-47% -$2.25M
MOFG
381
DELISTED
MidWestOne Financial Group
MOFG
$2.43M 0.02%
+70,792
New +$2.55M
ALK icon
382
Alaska Air
ALK
$5.63B
$2.42M 0.02%
+26,262
New +$2.48M
DFIN icon
383
Donnelley Financial Solutions
DFIN
$1.17B
$2.41M 0.02%
+125,000
New +$2.82M
BPMC
384
DELISTED
Blueprint Medicines
BPMC
$2.39M 0.02%
59,746
-40,254
-40% -$1.44M
SNDX icon
385
Syndax Pharmaceuticals
SNDX
$1.79B
$2.37M 0.02%
172,386
-52,614
-23% -$546K
CSLT
386
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$2.35M 0.02%
642,442
-7,558
-1% -$26.5K
CLGX
387
DELISTED
Corelogic, Inc.
CLGX
$2.29M 0.02%
+56,361
New +$2.14M
GNMK
388
DELISTED
GenMark Diagnostics, Inc
GNMK
$2.27M 0.02%
177,435
-2,088
-1% -$25.1K
WPX
389
DELISTED
WPX Energy, Inc.
WPX
$2.26M 0.02%
+168,576
New +$2.25M
CFRX
390
CALL
DELISTED
ContraFect Corporation
CFRX
$2.25M 0.02%
1,563
SAVE
391
DELISTED
Spirit Airlines, Inc.
SAVE
$2.25M 0.02%
+42,315
New +$2.26M
LJPC
392
DELISTED
La Jolla Pharmaceutical Company
LJPC
$2.24M 0.02%
+75,000
New +$1.91M
FDC
393
DELISTED
First Data Corporation
FDC
$2.21M 0.02%
+142,345
New +$2.23M
AYX
394
DELISTED
Alteryx Inc
AYX
$2.21M 0.02%
+141,070
New +$2.15M
ACGN
395
DELISTED
Aceragen Inc
ACGN
$2.17M 0.02%
6,465
-1,566
-19% -$378K
BLRX
396
BioLineRX
BLRX
$12.1M
$2.16M 0.02%
3,750
+2,679
+250% +$1.72M
ERIC icon
397
Ericsson
ERIC
$33.3B
$2.15M 0.02%
+324,502
New +$2M
CCP
398
DELISTED
Care Capital Properties, Inc.
CCP
$1.93M 0.02%
71,692
-103,064
-59% -$2.6M
TNDM icon
399
Tandem Diabetes Care
TNDM
$1.51B
$1.92M 0.02%
+160,000
New +$3.5M
LSI
400
DELISTED
Life Storage, Inc.
LSI
$1.85M 0.02%
33,785
-371,409
-92% -$20.8M

Similar funds

Alyeska Investment Group's Q1 2017 Portfolio in Review

As of Q1 2017, Alyeska Investment Group held 627 positions worth $12.3B, up 1.9% from $12.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Alyeska Investment Group's Q1 2017 filing shows 166 new, 116 increased, 155 reduced and 161 closed positions. Its largest new stake was Agilent Technologies: 2,378,330 shares worth $126M. The largest sale was Cisco, an estimated $141M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Alyeska Investment Group's largest Q1 2017 buy was Agilent Technologies: 2,378,330 shares worth $126M.
  • Alyeska Investment Group added most to Palo Alto Networks in Q1 2017, an estimated $167M increase.
  • Alyeska Investment Group's biggest Q1 2017 reduction was Cisco, cutting an estimated $141M.
  • Alyeska Investment Group fully exited Stryker in Q1 2017, selling an estimated $134M.
  • Alyeska Investment Group's ten largest holdings make up 12% of its $12.3B portfolio in Q1 2017.
  • Alyeska Investment Group opened 166 new positions and closed 161 in Q1 2017.
  • Alyeska Investment Group's portfolio value rose 1.9% quarter-over-quarter to $12.3B.

Based on Alyeska Investment Group's 13F filing for Q1 2017, filed 15 May 2017.